Pioneering Leadership in AI, Computational Medicine, and Data Analytics

RRI brings together physicians, data scientists, mathematicians, engineers, theoretical physicists, and analysts, all united by one purpose: to transform ground-breaking research into transformative clinical care. Viewing complex problems through multiple lenses broadens our perspective and opens new avenues of inquiry. The simple words “I have a thought” can spark a discovery or change the trajectory of a research project.

Our Focus Areas

We use AI, computational medicine, and advanced analytics to develop new clinical strategies, treatments, protocols, and diagnostic tools that support clinicians and improve outcomes for patients. We operate at the intersection of clinical data, machine data, and real-world practice, with access to a large patient population and one of the world's largest and richest renal datasets. Because we have access to data that spans over 20 countries, we also have a unique opportunity to answer global questions and evaluate the effectiveness of specific healthcare interventions.

Research Innovations

Our interdisciplinary approach, the quality of our data, and our agile development process all contribute to the breadth and depth of our innovations. We've pioneered models designed to optimize anemia management and help reduce hospitalizations, and identify dialysis patients most likely to benefit from home therapy. We’ve published over 600 peer-reviewed studies since 2000, contributing not only to innovation but to a growing body of evidence-based science that shapes practice and policy.

Latest Research & News

Latest Research

  • Peter Kotanko, Linda Hanna Ficociello, Frank van der Sande

    PURPOSE OF REVIEWThere are concerns that online high-dose hemodiafiltration (HDF) is particularly resource-intensive and environmentally challenging. It has recently been suggested that HDF consumes more water and generates more plastic waste than expanded hemodialysis (HDx) using medium cut-off membranes. To further address this matter, we examined the available evidence on water use and plastic waste generation across high-flux hemodialysis, HDx, and HDF.SUMMARYDespite the suggestive 'high-dose' attribute in its name, online high-dose HDF with optimized dialysate flow may use less water and generates substantially less plastic waste than HDx. These findings challenge the view that HDF adoption is environmentally costly and indicate that HDF is a meaningful step towards green dialysis.RECENT FINDINGSOur analysis reveals that plastic waste generation is lowest with HDF and highest with HDx: modern HDF dialyzers weigh on average 36% less than MCO dialyzers, and online HDF requires no saline bags, together saving approximately 68-123  kg of plastic per 1000 sessions compared to HDx. Regarding water, online high-dose HDF may use less water than HD or HDx if dialysate flow is minimized/optimized (-8% vs. hemodialysis at standard European dialysate flow; -12.6% in a US setting). Individualization of dialysate flow reduces water consumption by a further 27.8% without compromising dialysis adequacy.

No Results Found

Latest News

No Results Found

The MONDO Initiative

RRI is a founding member of the MONitoring Dialysis Outcomes (MONDO) initiative, an international consortium of kidney care providers, academic institutions, and subject matter experts dedicated to advancing data-driven research on kidney disease. MONDO integrates clinical data, domain expertise, and advanced analytics to:

• Deepen understanding of patient characteristics, practice patterns, and physiology
• Evaluate the real-world generalizability of therapies and technologies
• Develop advanced models and AI-driven solutions to improve outcomes